Trials / Unknown
UnknownNCT03848637
The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375
A Randomized, Open-label, Single Dose, 2-period, 2-treatment, Crossover Study to Compare the Pharmacokinetics and Safety/Tolerability of CKD-375 Tablet With D387 Tablet in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-375 and D387 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-375 | Test drug |
| DRUG | D387 | Reference drug |
Timeline
- Start date
- 2019-04-14
- Primary completion
- 2019-04-24
- Completion
- 2019-05-01
- First posted
- 2019-02-21
- Last updated
- 2019-03-06
Source: ClinicalTrials.gov record NCT03848637. Inclusion in this directory is not an endorsement.